Bond K M, Brinjikji W, Murad M H, Kallmes D F, Cloft H J, Lanzino G
From the Mayo Medical School (K.M.B.).
Department of Radiology (W.B., D.F.K., H.J.C.)
AJNR Am J Neuroradiol. 2017 Feb;38(2):304-309. doi: 10.3174/ajnr.A4989. Epub 2016 Nov 17.
Endovascular treatment of intracranial aneurysms is associated with the risk of thromboembolic ischemic complications. Many of these events are asymptomatic and identified only on diffusion-weighted imaging. We performed a systematic review and meta-analysis to study the incidence of DWI positive for thromboembolic events following endovascular treatment of intracranial aneurysms.
A comprehensive literature search identified studies published between 2000 and April 2016 that reported postprocedural DWI findings in patients undergoing endovascular treatment of intracranial aneurysms. The primary outcome was the incidence of DWI positive for thromboembolic events. We examined outcomes by treatment type, sex, and aneurysm characteristics. Meta-analyses were performed by using a random-effects model.
Twenty-two studies with 2148 patients and 2268 aneurysms were included. The overall incidence of DWI positive for thromboembolic events following endovascular treatment was 49% (95% CI, 42%-56%). Treatment with flow diversion trended toward a higher rate of DWI positive for lesions than coiling alone (67%; 95% CI, 46%-85%; versus 45%; 95% CI, 33%-56%; = .07). There was no difference between patients treated with coiling alone and those treated with balloon-assisted (44%; 95% CI, 29%-60%; = .99) or stent-assisted (43%; 95% CI, 24%-63%; = .89) coiling. Sex, aneurysm rupture status, location, and size were not associated with the rate of DWI positive for lesions.
One in 2 patients may have infarcts on DWI following endovascular treatment of intracranial aneurysms. There is a trend toward a higher incidence of DWI-positive lesions following treatment with flow diversion compared with coiling. Patient demographics and aneurysm characteristics were not associated with DWI-positive thromboembolic events.
颅内动脉瘤的血管内治疗存在血栓栓塞性缺血并发症的风险。其中许多事件是无症状的,仅在扩散加权成像上才能发现。我们进行了一项系统评价和荟萃分析,以研究颅内动脉瘤血管内治疗后血栓栓塞事件的扩散加权成像(DWI)阳性发生率。
通过全面的文献检索,确定了2000年至2016年4月间发表的研究,这些研究报告了接受颅内动脉瘤血管内治疗患者的术后DWI结果。主要结局是血栓栓塞事件的DWI阳性发生率。我们按治疗类型、性别和动脉瘤特征检查了结局。采用随机效应模型进行荟萃分析。
纳入了22项研究,共2148例患者和2268个动脉瘤。血管内治疗后血栓栓塞事件的DWI阳性总体发生率为49%(95%可信区间[CI],42%-56%)。与单纯弹簧圈栓塞相比,血流导向治疗的病变DWI阳性率有升高趋势(67%;95%CI,46%-85%;相比之下,单纯弹簧圈栓塞为45%;95%CI,33%-56%;P = 0.07)。单纯弹簧圈栓塞治疗的患者与球囊辅助(44%;95%CI,29%-60%;P = 0.99)或支架辅助(43%;95%CI,24%-63%;P = 0.89)弹簧圈栓塞治疗的患者之间无差异。性别、动脉瘤破裂状态、位置和大小与病变的DWI阳性率无关。
颅内动脉瘤血管内治疗后,每2例患者中可能有1例在DWI上出现梗死灶。与弹簧圈栓塞相比,血流导向治疗后DWI阳性病变的发生率有升高趋势。患者人口统计学特征和动脉瘤特征与DWI阳性血栓栓塞事件无关。